(Q44420155)

2 December 2017

Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease (English)

1 reference

2 December 2017

0 references

Sankar Surendran

2

0 references

Gerald A. Campbell

object named as

Gerald A Campbell

5

0 references

author name string

Reuben Matalon

1

1 reference

2 December 2017

Peter L Rady

3

1 reference

2 December 2017

Michael J Quast

4

1 reference

2 December 2017

Kimberlee M Matalon

6

1 reference

2 December 2017

Stephen K Tyring

7

1 reference

2 December 2017

Jingna Wei

8

1 reference

2 December 2017

Carmen S Peden

9

1 reference

2 December 2017

E L Ezell

10

1 reference

2 December 2017

Nicholas Muzyczka

11

1 reference

2 December 2017

Ronald J Mandel

12

1 reference

2 December 2017

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

7

1 reference

2 December 2017

5 Pt 1

1 reference

2 December 2017

580-587

1 reference

Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with canavan disease

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Canavan disease: a review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Transfer of a foreign gene into the brain using adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Gene therapy in the central nervous system: the use of recombinant retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

SSIEM Award. Aspartoacylase deficiency: the enzyme defect in Canavan disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Canavan disease: biochemical and molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

SCHILDER'S ENCEPHALITIS PERIAXIALIS DIFFUSA

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type).

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Cerebral spongy degeneration of infancy. A biochemical and ultrastructural study of affected twins.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

1 reference

7 January 2021

Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Selective and rapid uptake of adeno-associated virus type 2 in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Production and purification of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Adeno-associated virus general transduction vectors: analysis of proviral structures

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Malonyl CoA decarboxylase deficiency: C to T transition in intron 2 of the MCD gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

Spatial localization in NMR spectroscopy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900066-2

7 January 2021

10.1016/S1525-0016(03)00066-2

Identifiers

DOI

1 reference

2 December 2017

1 reference